You are viewing: US Cell Analysis Market analysis
Part of: Cell Analysis Market (Global)

The US Cell Analysis Market was valued at $2826.33 Million in 2023 and projected to reach to $4454.09 Million by 2028, representing a compound annual growth rate of 9.5%. The US cell analysis market is poised for sustained growth through 2028, driven by increasing demand for precision medicine, personalized diagnostics, and advanced research capabilities.

US Cell Analysis Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Cell Analysis Market Trends and Insights

  • This growth trajectory reflects the US healthcare sector's increasing investment in advanced diagnostic and research technologies that enable cellular-level analysis and characterization.
  • The US market benefits from robust pharmaceutical R&D spending, widespread adoption of flow cytometry and imaging platforms, and strong demand from academic and clinical laboratories. Driving expansion across the forecast period, the US cell analysis market is supported by rising prevalence of chronic diseases, accelerating personalized medicine initiatives, and technological innovations in automation and artificial intelligence.
  • US healthcare institutions continue to prioritize cell-based diagnostics for cancer detection, immunology research, and regenerative medicine applications.
  • The competitive landscape in the US remains dynamic, with both established diagnostic manufacturers and emerging biotech firms investing heavily in next-generation cell analysis solutions to capture market share..

Key Market Statistics

  • CAGR (2023-2028) 9.5% CAGR
  • Market Size, 2023 ~USD 2826.33 Million
  • Forecast, 2028 ~USD 4454.09 Million
  • Country US

US Cell Analysis Market Overview

Market Valuation Growth :

The US cell analysis market reached $2,826.33 million in 2023 and is expected to grow to $4,454.09 million by 2028, driven by increasing adoption of advanced diagnostic technologies across American healthcare institutions.

Strong CAGR Performance :

The US market is expanding at a 9.5% CAGR, reflecting robust investment in cellular research infrastructure and diagnostic capabilities within the American healthcare and life sciences sectors.

Advanced Healthcare Infrastructure :

The US benefits from well-established research institutions, leading pharmaceutical companies, and significant government funding for biomedical research, accelerating cell analysis technology adoption.

Regulatory Support & Innovation :

FDA approvals and regulatory frameworks supporting advanced diagnostic tools, combined with strong venture capital investment, are propelling innovation in US cell analysis solutions.

US Cell Analysis Market Dynamics

  • Healthcare providers and research institutions are investing heavily in cell analysis technologies to improve patient outcomes and accelerate drug discovery processes.
  • The market's 9.5% CAGR reflects strong momentum in oncology, immunology, and regenerative medicine applications. Key growth drivers include rising cancer prevalence, expanding clinical applications, and integration of artificial intelligence with cell analysis platforms.
  • The US market's maturity and high healthcare spending create favorable conditions for premium technology adoption.
  • Continued investment in biotechnology infrastructure and increasing collaboration between academic institutions and commercial entities will further strengthen market expansion through the forecast period..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • The US cell analysis market is projected to grow from $2,826.33M in 2023 to $4,454.09M by 2028 at a 9.5% CAGR.
      • US pharmaceutical and biotech companies drive significant demand for advanced cell analysis technologies in drug development and clinical diagnostics.
      • Automation, AI integration, and high-content screening platforms are reshaping the US cell analysis competitive landscape.
      • The US market is supported by strong healthcare infrastructure, regulatory frameworks, and substantial R&D investment across academic and commercial sectors.

      Cell Analysis Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment SINGLE-CELL ANALYSIS (Process)
      Forecast Period 2023–2028
      Growth Rate CAGR of 10.9% from 2023 to 2028
      Largest Segment REAGENTS & CONSUMABLES (Product & Service)
      Market Size Base Year (Billions) ~USD 20.21 (2023)
      Revenue Forecast (Billions) ~USD 33.9 (2028)
      Segments Covered Product & Service, Technique, Process, End User

      US Cell Analysis Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product & Service

      • Accessories
      • Instruments
      • Reagents & Consumables
      • Services
      • Software

      By Technique

      • Cell Microarrays
      • Flow Cytometry
      • High-Content Screening
      • Microscopy
      • Other Techniques
      • Pcr
      • Spectrophotometry

      By Process

      • Cell Counting And Quality Control
      • Cell Identification
      • Cell Interaction
      • Cell Proliferation
      • Cell Signaling Pathways/ Signal Transduction
      • Cell Signaling Pathways/Signal Transduction
      • Cell Structure Study
      • Cell Viability
      • Single-Cell Analysis
      • Target Identification And Validation

      By End User

      • Academic And Research Institutes
      • Hospitals And Clinical Testing Laboratories
      • Other End Users
      • Pharmaceutica And Biotechnology Companies
      • Pharmaceutical & Biotechnology Companies
      • Pharmaceutical And Biotechnology Companies

      US: CELL ANALYSIS MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      ACADEMIC AND RESEARCH INSTITUTES965.381096.481179.961276.691391.341527.171688.191881.049.8
      HOSPITALS AND CLINICAL TESTING LABORATORIES1233.261404.021514.461642.451794.141973.892187.112442.6410
      OTHER END USERS1374.161562.891684.181824.751991.332188.712422.792703.259.9
      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES1912.862170.732333.972523.122747.313012.873327.623704.519.7
      TOTAL5485.656234.116712.577267.017924.128702.649625.710731.459.8

      Target Audience

      • Medical Device Manufacturers : US-based and international device companies need market sizing and growth forecasts to develop product roadmaps, allocate R&D budgets, and identify market entry opportunities in the American cell analysis sector.
      • Pharmaceutical & Biotech Companies : Drug developers and biotech firms require US market intelligence to assess demand for cell analysis tools in drug discovery, clinical trials, and personalized medicine applications within American research institutions.
      • Healthcare Providers & Hospitals : US hospital systems and diagnostic centers need market data to evaluate technology investments, benchmark adoption rates, and understand competitive offerings in cell analysis solutions for clinical diagnostics.
      • Investment & Private Equity Firms : Investors targeting the US healthcare technology sector require validated market forecasts and growth metrics to evaluate investment opportunities and assess portfolio company performance in cell analysis.
      • Research Institutions & Universities : US academic medical centers and research organizations need market insights to justify funding requests, understand technology trends, and identify collaboration opportunities with commercial cell analysis providers.

      Key Companies in the US Cell Analysis Market

      CompanyHQOwnershipStrongest segments
      PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing & packaging),Pharmaceutical development services (formulation & clinical supply),Drug substance services (API & biologics),
      ABCAM PLCUnited KingdomPrivate CompanyPrimary and secondary antibodies,Conjugated antibodies and conjugation kits,Singleplex immunoassays,
      BRUKER CORPORATIONUnited StatesPublic CompanyBSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry and diagnostics),BSI Nano (X-ray, AFM, microscopy, nano-metrology),
      WAFERGEN BIO-SYSTEMSUnited StatesPrivate CompanySmartChip Real-Time PCR and Target Enrichment Systems,SmartChip Single-Cell Isolation System,Apollo 324 Library Preparation System and Reagents,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      DANAHERUnited StatesPublic CompanyBiotechnology (bioprocessing and single-use solutions),Life Sciences (instruments, genomics, and analytical systems),Diagnostics (clinical instruments and consumables),
      GENERAL ELECTRICUnited StatesPublic CompanyCommercial Engines & Services,Defense & Propulsion Technologies,Additive, Components & Other Systems,
      MERCK KGAAGermanyPublic CompanyLife Science (reagents, consumables, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, equipment),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research and Bioprocess,
      STANDARD BIOTOOLSUnited StatesPublic CompanyProteomics platforms and consumables (SomaScan, CyTOF, Hyperion),Genomics platforms and consumables (Biomark X9 and legacy systems),Services, software, and other,
      OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Urology (visualization, stone management, BPH, bladder cancer),Respiratory (bronchoscopy, lung cancer, COPD),

      PATHEON INC

      Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and biotechnology services sector.

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees providing research reagents and tools for the life sciences industry.

      BRUKER CORPORATION

      Bruker Corporation is a publicly traded U.S. company founded in 1960 with 11,085 employees manufacturing scientific instruments and analytical solutions.

      WAFERGEN BIO-SYSTEMS

      WaferGen Bio-Systems is a U.S. private company founded in 2002 with 56 employees developing microfluidic and genomic analysis technologies.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a publicly traded U.S. company founded in 1956 with 125,000 employees serving the life sciences, analytical, and diagnostics markets.

      DANAHER

      Danaher is a publicly traded U.S. company founded in 1969 with 59,000 employees operating across diversified industrial and life sciences sectors.

      GENERAL ELECTRIC

      General Electric is a publicly traded U.S. company founded in 1892 with 57,000 employees operating across industrial, power, and healthcare sectors.

      MERCK KGAA

      Merck KGaA is a publicly traded German company founded in 1668 with 59,077 employees engaged in pharmaceuticals, life sciences, and performance materials.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a publicly traded U.S. company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a publicly traded U.S. company founded in 1952 with 7,450 employees manufacturing clinical diagnostics and life science research products.

      STANDARD BIOTOOLS

      Standard Biotools is a publicly traded U.S. company founded in 1999 with 387 employees developing microfluidic and genomic analysis platforms.

      OLYMPUS CORPORATION

      Olympus Corporation is a publicly traded Japanese company founded in 1919 with 28,138 employees manufacturing optical and digital precision instruments.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for the US cell analysis market with verified 2023 baseline ($2.8B) and 2028 forecast ($4.5B), enabling accurate business planning and investment decisions specific to the American market.
      • Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, market consolidation trends, and key player strategies to identify partnership opportunities and competitive positioning within the American healthcare ecosystem.
      • Regional Growth Drivers Analysis : Access detailed insights into US-specific factors driving the 9.5% CAGR, including regulatory environment, healthcare spending patterns, and technology adoption rates unique to American institutions.
      • Investment & Expansion Strategy : Make informed decisions on market entry, expansion, or acquisition strategies in the US with comprehensive data on market segments, customer needs, and growth opportunities across American healthcare sectors.
      • Forecast Accuracy & Planning : Leverage validated market projections through 2028 to develop realistic revenue forecasts, resource allocation plans, and go-to-market strategies tailored to the US cell analysis market trajectory.

      Frequently asked questions

      What is the current size of the US cell analysis market?

      The US cell analysis market was valued at $2,826.33 million in 2023 and is expected to reach $4,454.09 million by 2028.

      What is the projected growth rate for the US cell analysis market?

      The US cell analysis market is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2023 to 2028.

      Which technologies dominate the US cell analysis market?

      Flow cytometry, high-content imaging, automated cell counters, and AI-powered image analysis platforms are among the leading technologies in the US market.

      What are the primary drivers of growth in the US cell analysis market?

      Key drivers include rising chronic disease prevalence, increased personalized medicine adoption, pharmaceutical R&D expansion, and technological innovations in automation and artificial intelligence.

      Who are the main end-users of cell analysis solutions in the US?

      Primary end-users include pharmaceutical and biotechnology companies, academic research institutions, clinical diagnostic laboratories, and hospital pathology departments across the US.

      RESEARCH METHODOLOGY

      This study involved four major activities in estimating the current size of the cell analysis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), Society for Laboratory Automation and Screening (SLAS), Centers for Medicare & Medicaid Services (CMS), National Cancer Institute (NCI), European Commission (EC), American Society for Cell Biology (ASCB), European Society for Toxicology In Vitro (ESTIV), European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan Society for Cell Biology (JSCB), Shanghai Institute of Biochemistry and Cell Biology (SIBCB), Indian Society of Cell Biology (ISCB), Food and Drug Administration (FDA), Society of Biomolecular Imaging and Informatics (SBI2), Annual Reports, SEC Filings, Investor Presentations, Press Releases, Conferences, Journals, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

      Cell Analysis Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue. As of 2021, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and market have been identified through extensive secondary research
      • The revenues generated from the cell analysis business of leading players have been determined through primary and secondary research
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Cell Analysis Market Size, and Share

      Data Triangulation

      After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Cell analysis is a technique used to study groups of cells and individual cells based on multiple parameters. It is used to measure cell properties such as size, shape, presence of specific proteins, proliferation, growth, morphology, porosity, and complexity.

      Cell analysis products are used in various processes, which include cell identification, cell viability, cell proliferation, cell structure study, cell signaling pathway/signal transduction, cell counting & quality control, target identification & validation, cell interaction, and single-cell analysis. These processes are carried out by various end users such as hospitals & clinical testing laboratories, academic and research institutes, pharmaceutical & biotechnology companies, and other end users (CROs, cell culture collection repositories, food & beverage manufacturers, environmental monitoring organizations, forensic laboratories, and blood banks).

      Key Stakeholders

      • Pharmaceutical and biopharmaceutical companies
      • Manufacturers of cell analysis equipment
      • Contract research organizations (CROs)
      • Life science research institutes
      • Venture capitalists
      • Research & consulting firms

      Report Objectives

      • To define, describe, and forecast the global cell analysis market based on the product & service, technique, process, end user and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall cell analysis market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the cell analysis market.

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

      Company Information

      • An additional five company profiles

      Get the Full Cell Analysis Market Report

      Full forecast, segment splits, and company analysis for all Cell Analysis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status